ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 7 (4) 257-269    DOI: 10.1677/erc.0.0070257
Copyright © 2000 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, R
Right arrow Articles by Adam, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, R
Right arrow Articles by Adam, L
Endocrine Related Cancer, Vol 7, Issue 4, 257-269
Copyright © 2000 by Society for Endocrinology


Articles

Apoptosis in mammary gland and cancer

R Kumar, RK Vadlamudi, and L Adam


Homeostasis in normal tissue is regulated by a balance between proliferative activity and cell loss by apoptosis. Apoptosis is a physiological mechanism of cell loss that depends on both pre-existing proteins and de novo protein synthesis, and the process of apoptosis is integral to normal mammary gland development and in many diseases, including breast cancer. The mammary gland is one of the few organ systems in mammals that completes its morphologic development postnatally during two discrete physiologic states, puberty and pregnancy. The susceptibility of the mammary gland to tumorigenesis is influenced by its normal development, particularly during stages of puberty and pregnancy that are characterized by marked alterations in breast cell proliferation and differentiation. Numerous epidemiologic studies have suggested that specific details in the development of the mammary gland play a critical role in breast cancer risk. Mammary gland development is characterized by dynamic changes in the expression profiles of Bcl-2 family members. The expression of Bcl-2 family proteins in breast cancer is also influenced by estradiol and by progestin. Since the ratio of proapoptotic to antiapoptotic proteins determines apoptosis or cell survival, hormone levels may have important implications in the therapeutic prevention of breast cancer.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. S. Bachmann, F. Otterbach, R. Callies, H. Nuckel, M. Bau, K. W. Schmid, W. Siffert, and R. Kimmig
The AA Genotype of the Regulatory BCL2 Promoter Polymorphism ( 938C>A) Is Associated with a Favorable Outcome in Lymph Node Negative Invasive Breast Cancer Patients
Clin. Cancer Res., October 1, 2007; 13(19): 5790 - 5797.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Shah and P. W. Sylvester
Tocotrienol-Induced Caspase-8 Activation Is Unrelated to Death Receptor Apoptotic Signaling in Neoplastic Mammary Epithelial Cells
Experimental Biology and Medicine, September 1, 2004; 229(8): 745 - 755.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Li, S. Das, T. Yamada, and H. H. Samuels
The NRIF3 Family of Transcriptional Coregulators Induces Rapid and Profound Apoptosis in Breast Cancer Cells
Mol. Cell. Biol., May 1, 2004; 24(9): 3838 - 3848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Lee, C.-T. Lin, L.-L. Chueh, and C.-J. Chang
Autocrine/Paracrine Secreted Frizzled-related Protein 2 Induces Cellular Resistance to Apoptosis: A POSSIBLE MECHANISM OF MAMMARY TUMORIGENESIS
J. Biol. Chem., April 9, 2004; 279(15): 14602 - 14609.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Li, J. Backer, A. S. K. Wong, E. L. Schwanke, B. G. Stewart, and M. Pasdar
Bcl-2 expression decreases cadherin-mediated cell-cell adhesion
J. Cell Sci., September 15, 2003; 116(18): 3687 - 3700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Sawyer, J. Sturge, D. C. Bennett, M. J. O'Hare, W. E. Allen, J. Bain, G. E. Jones, and B. Vanhaesebroeck
Regulation of Breast Cancer Cell Chemotaxis by the Phosphoinositide 3-Kinase p110{delta}
Cancer Res., April 1, 2003; 63(7): 1667 - 1675.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. M. Minter, E. S. Dickinson, S. P. Naber, and D. J. Jerry
Epithelial cell cycling predicts p53 responsiveness to {gamma}-irradiation during post-natal mammary gland development
Development, March 8, 2003; 129(12): 2997 - 3008.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Vargo-Gogola, B. Fingleton, H. C. Crawford, and L. M. Matrisian
Matrilysin (Matrix Metalloproteinase-7) Selects for Apoptosis-resistant Mammary Cells in Vivo
Cancer Res., October 1, 2002; 62(19): 5559 - 5563.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Parton, M. Dowsett, and I. Smith
Studies of apoptosis in breast cancer
BMJ, June 23, 2001; 322(7301): 1528 - 1532.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Endocrinology.